BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 28970173)

  • 81. Spread of plasmids containing the bla(VIM-1) and bla(CTX-M) genes and the qnr determinant in Enterobacter cloacae, Klebsiella pneumoniae and Klebsiella oxytoca isolates.
    Miró E; Segura C; Navarro F; Sorlí L; Coll P; Horcajada JP; Alvarez-Lerma F; Salvadó M
    J Antimicrob Chemother; 2010 Apr; 65(4):661-5. PubMed ID: 20089541
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Characterization of Piperacillin/Tazobactam-Resistant Klebsiella oxytoca Recovered from a Nosocomial Outbreak.
    Fujita A; Kimura K; Yokoyama S; Jin W; Wachino J; Yamada K; Suematsu H; Yamagishi Y; Mikamo H; Arakawa Y
    PLoS One; 2015; 10(11):e0142366. PubMed ID: 26539828
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Bactericidal activity of human serum against strains of Klebsiella from different sources.
    Benge GR
    J Med Microbiol; 1988 Sep; 27(1):11-5. PubMed ID: 3050105
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations.
    Viscidi R; Willey S; Bartlett JG
    Gastroenterology; 1981 Jul; 81(1):5-9. PubMed ID: 7239125
    [TBL] [Abstract][Full Text] [Related]  

  • 85. [Acute colitis with Klebsiella oxytoca septicemia].
    Tissot B; Demy M; Blanchi A; Pillette C
    Gastroenterol Clin Biol; 2006; 30(8-9):1108. PubMed ID: 17075463
    [No Abstract]   [Full Text] [Related]  

  • 86. CTX-M-producing Klebsiella spp. in a Brazilian hospital: what has changed in 6 years?
    Clímaco EC; Minarini LA; da Costa Darini AL
    Diagn Microbiol Infect Dis; 2010 Oct; 68(2):186-9. PubMed ID: 20846594
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Klebsiella oxytoca: opportunistic infections in laboratory rodents.
    Bleich A; Kirsch P; Sahly H; Fahey J; Smoczek A; Hedrich HJ; Sundberg JP
    Lab Anim; 2008 Jul; 42(3):369-75. PubMed ID: 18625592
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Molecular Detection and Phylogenetic Analysis of the alkB Gene in
    Mupamhadzi TL; Machona O; Chidzwondo F; Mangoyi R
    ScientificWorldJournal; 2024; 2024():3350591. PubMed ID: 38756480
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Analysis of plasmid-mediated multidrug resistance in Escherichia coli and Klebsiella oxytoca isolates from clinical specimens in Japan.
    Ode T; Saito R; Kumita W; Sato K; Okugawa S; Moriya K; Koike K; Okamura N
    Int J Antimicrob Agents; 2009 Oct; 34(4):347-50. PubMed ID: 19560903
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Use of automated repetitive-sequence-based PCR for rapid laboratory confirmation of nosocomial outbreaks.
    Grisold AJ; Zarfel G; Strenger V; Feierl G; Leitner E; Masoud L; Hoenigl M; Raggam RB; Dosch V; Marth E
    J Infect; 2010 Jan; 60(1):44-51. PubMed ID: 19879293
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Molecular Confirmation of an Indole-Negative Klebsiella oxytoca Isolated from a Patient with Cystitis.
    Takano Y; Shibano M; Takizawa Y; Arai E; Koyama S; Shimizu T; Matsumoto T
    Jpn J Infect Dis; 2023 Mar; 76(2):159-161. PubMed ID: 36575027
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Characterization and genome analysis of novel bacteriophages infecting the opportunistic human pathogens Klebsiella oxytoca and K. pneumoniae.
    Park EA; Kim YT; Cho JH; Ryu S; Lee JH
    Arch Virol; 2017 Apr; 162(4):1129-1139. PubMed ID: 28028618
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Improved molecular characterization of the
    Shibu P; McCuaig F; McCartney AL; Kujawska M; Hall LJ; Hoyles L
    Microb Genom; 2021 Jun; 7(6):. PubMed ID: 34142942
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Septicemia caused by Klebsiella oxytoca.
    Umenai T; Saitoh Y; Chiba M
    Tohoku J Exp Med; 1978 Apr; 124(4):393-4. PubMed ID: 663938
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Pseudo-outbreak of Klebsiella oxytoca spontaneous bacterial peritonitis attributed to contamination of multidose vials of culture medium supplement.
    Perez F; Deshpande A; Kundrapu S; Hujer AM; Bonomo RA; Donskey CJ
    Infect Control Hosp Epidemiol; 2014 Feb; 35(2):139-43. PubMed ID: 24442075
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Characterisation, biotyping, antibiogram and klebocin typing of Klebsiella with special reference to Klebsiella oxytoca.
    Aggarwal A; Khanna S; Arora U
    Indian J Med Sci; 2003 Feb; 57(2):68-70. PubMed ID: 14514272
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Clostridium difficile and its cytotoxin in diarrhoeic stools of hospitalized patients. Toxigenic potential of the isolates.
    De Barbeyrac B; Guinet R; Quentin C; Cantet P; Bebear C
    Ann Biol Clin (Paris); 1989; 47(2):67-70. PubMed ID: 2660635
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Clostridium difficile culture-positive toxin-negative diarrhea.
    Lashner BA; Todorczuk J; Sahm DF; Hanauer SB
    Am J Gastroenterol; 1986 Oct; 81(10):940-3. PubMed ID: 3766495
    [TBL] [Abstract][Full Text] [Related]  

  • 99. A cluster of nosocomial Klebsiella oxytoca bloodstream infections in a university hospital.
    Sardan YC; Zarakolu P; Altun B; Yildirim A; Yildirim G; Hascelik G; Uzun O
    Infect Control Hosp Epidemiol; 2004 Oct; 25(10):878-82. PubMed ID: 15518033
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Isolation of multidrug-resistant Klebsiella oxytoca carrying blaIMP-8, associated with OXY hyperproduction, in the intensive care unit of a community hospital in Spain.
    Conejo MC; Domínguez MC; López-Cerero L; Serrano L; Rodríguez-Baño J; Pascual A
    J Antimicrob Chemother; 2010 May; 65(5):1071-3. PubMed ID: 20215129
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.